Outpatient Inhaled Corticosteroid Use in Bronchopulmonary Dysplasia
Cynara Leon, MD, MPH1, Amanda Martin, BA1, Lisa R. Young, MD1, Brianna C. Aoyama, MD, MHS2, Jessica L. Rice, MD, MHS1, Jelte Kelchtermans, MD1, Joseph M. Collaco, MD, PhD 2, Sharon A. McGrath-Morrow, MD, MBA1*
1Division of Pulmonary and Sleep Medicine, Children’s Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA
2Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University, Baltimore, MD
*Corresponding Author: Sharon A. McGrath‐Morrow, MD, MBA, Division of Pulmonary and Sleep Medicine, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Email: mcgrathmos@chop.edu
Funding/Support : This work was supported by a R03HD109442 (JMC, SAM), T32-HL160493-01 (CL, JK), RFA-ES-18-003 (SAM), Parker B Francis Foundation (JK) and K24HL143281 (LRY).
The funding sources had no involvement in the writing of the manuscript or the decision to submit.
Keywords: inhaled corticosteroids, bronchopulmonary dysplasia, outpatient, symptoms, acute care use
Running Head: Inhaled corticosteroids and BPD